【KINS × Paramount Bed】Executive Wellness Event on "Sleep × Gut Health Habits" to Support Daily Condition Management for Business Leaders, Held on May 12 (Tuesday)
KINS and Paramount Bed will jointly host a wellness event on "Sleep × Gut Health Habits" for executives and board members on May 12, 2026. The event aims to improve business performance by offering the latest insights and sleep tech experiences.
📋 Article Processing Timeline
- 📰 Published: May 7, 2026 at 20:10
- 🔍 Collected: May 7, 2026 at 11:31
- 🤖 AI Analyzed: May 8, 2026 at 01:56 (14h 24m after Collected)
KINS Co., Ltd. (Headquarters: Koto-ku, Tokyo; Representative Director: Minoru Shimokawa; hereinafter "KINS"), which develops comprehensive microbial care services, will hold a special wellness event "Sleep × Gut Health Strategy for Improving Business Performance" for executives and board members on May 12, 2026 (Tuesday) at Paramount Bed's directly managed store "Paramount Bed Sleep Gallery TOKYO," with the cooperation of Paramount Bed Co., Ltd. (Headquarters: Koto-ku, Tokyo; President: Tomohiko Kimura; hereinafter "Paramount Bed").
■ Background of the Event: Redefining "Health Management" as a Business Foundation
For all those who continue to play an active role on the front lines of business, "health" is an irreplaceable and vital business foundation. In particular, research focusing on the relationship between the condition of the "brain," which supports daily business decisions, and "sleep" and "gut environment" has been attracting attention in recent years.
For busy executives, chronic sleep deprivation and changes in the gut environment can affect daily condition, making it one of the health habits that business leaders should pay attention to. At this event, based on the latest research findings on sleep and gut health, we will propose wellness habits that support executives in building healthy routines.
■ Event Overview: "Understanding" the Latest Knowledge and "Experiencing" Technology
At this event, Professor Yuji Naito of Kyoto Prefectural University of Medicine, a leading authority in gut bacteria research, and Minoru Shimokawa, CEO of KINS, will hold a dialogue. They will introduce the latest research findings on the theme of "How Sleep × Gut Health Changes Business Performance." In addition, at Paramount Bed's directly managed store "Paramount Bed Sleep Gallery TOKYO," the venue for the event, participants will have time to actually experience products equipped with sleep tech that aims to improve sleep with the latest technology, deepening their understanding of wellness from both theoretical and experiential aspects.
■ Speaker Profiles
◎ Professor Yuji Naito (Kyoto Prefectural University of Medicine) A researcher who conducts multifaceted research on the relationship between the gut environment and health, and has published numerous papers and books. While teaching for many years as a gastroenterologist, he has extensively researched the gut microbiota and published numerous papers and books.
◎ Minoru Shimokawa (Representative Director, KINS Co., Ltd.) After graduating from Okayama University School of Dentistry, he worked as a dentist. He founded KINS with an approach that utilizes gut environment improvement for the fundamental treatment of chronic diseases. He develops the strategic wellness program "KINS PRIME" for executives.
■ Implementation Details
Item | Content
---|---
Date | May 12, 2026 (Tuesday) 19:00 - 21:00 (Doors open 18:50)
Venue | Paramount Bed Sleep Gallery TOKYO
Participation Fee | 10,000 JPY (tax included) *Advance registration required
Capacity | Limited to 30 people
Target Audience | Executives and board members in their 40s and 50s residing in Tokyo
Organizer | KINS Co., Ltd.
Cooperation | Paramount Bed Co., Ltd.
Content | ・Special dialogue between Professor Yuji Naito and KINS CEO Minoru Shimokawa
| ・Paramount Bed's sleep tech experience
| ・Introduction to KINS PRIME individual consulting, etc.
(Paramount Bed Sleep Gallery TOKYO)
About KINS
KINS Co., Ltd. is a microbiome-focused health tech company with the mission to "free the world from chronic diseases and symptoms through the power of microbes." Its strength lies in combining medical expertise and B2C marketing expertise. It integrates three businesses: a product business (targeting women and men) with over 120,000 cumulative users, a clinic business (2 animal hospitals in Japan and 1 human clinic in Singapore) as a place for treating chronic diseases and symptoms related to microbes and clinical research, and a drug discovery business aiming for new treatments for chronic diseases and symptoms using data and samples obtained from both businesses. KINS aims to free more people from various microbe-related chronic diseases and symptoms in men, women, and animals.
Company Profile
Company Name: KINS Co., Ltd.
Location: 1-17-8-328 Shinkiba, Koto-ku, Tokyo
Representative: Minoru Shimokawa
Business Description: Product business, clinic business, and drug discovery business based on microbiome research
Official Website: https://corporate.yourkins.com/
[Inquiries from media regarding this matter]
KINS Co., Ltd. Public Relations: pr@yourkins.com
■ Background of the Event: Redefining "Health Management" as a Business Foundation
For all those who continue to play an active role on the front lines of business, "health" is an irreplaceable and vital business foundation. In particular, research focusing on the relationship between the condition of the "brain," which supports daily business decisions, and "sleep" and "gut environment" has been attracting attention in recent years.
For busy executives, chronic sleep deprivation and changes in the gut environment can affect daily condition, making it one of the health habits that business leaders should pay attention to. At this event, based on the latest research findings on sleep and gut health, we will propose wellness habits that support executives in building healthy routines.
■ Event Overview: "Understanding" the Latest Knowledge and "Experiencing" Technology
At this event, Professor Yuji Naito of Kyoto Prefectural University of Medicine, a leading authority in gut bacteria research, and Minoru Shimokawa, CEO of KINS, will hold a dialogue. They will introduce the latest research findings on the theme of "How Sleep × Gut Health Changes Business Performance." In addition, at Paramount Bed's directly managed store "Paramount Bed Sleep Gallery TOKYO," the venue for the event, participants will have time to actually experience products equipped with sleep tech that aims to improve sleep with the latest technology, deepening their understanding of wellness from both theoretical and experiential aspects.
■ Speaker Profiles
◎ Professor Yuji Naito (Kyoto Prefectural University of Medicine) A researcher who conducts multifaceted research on the relationship between the gut environment and health, and has published numerous papers and books. While teaching for many years as a gastroenterologist, he has extensively researched the gut microbiota and published numerous papers and books.
◎ Minoru Shimokawa (Representative Director, KINS Co., Ltd.) After graduating from Okayama University School of Dentistry, he worked as a dentist. He founded KINS with an approach that utilizes gut environment improvement for the fundamental treatment of chronic diseases. He develops the strategic wellness program "KINS PRIME" for executives.
■ Implementation Details
Item | Content
---|---
Date | May 12, 2026 (Tuesday) 19:00 - 21:00 (Doors open 18:50)
Venue | Paramount Bed Sleep Gallery TOKYO
Participation Fee | 10,000 JPY (tax included) *Advance registration required
Capacity | Limited to 30 people
Target Audience | Executives and board members in their 40s and 50s residing in Tokyo
Organizer | KINS Co., Ltd.
Cooperation | Paramount Bed Co., Ltd.
Content | ・Special dialogue between Professor Yuji Naito and KINS CEO Minoru Shimokawa
| ・Paramount Bed's sleep tech experience
| ・Introduction to KINS PRIME individual consulting, etc.
(Paramount Bed Sleep Gallery TOKYO)
About KINS
KINS Co., Ltd. is a microbiome-focused health tech company with the mission to "free the world from chronic diseases and symptoms through the power of microbes." Its strength lies in combining medical expertise and B2C marketing expertise. It integrates three businesses: a product business (targeting women and men) with over 120,000 cumulative users, a clinic business (2 animal hospitals in Japan and 1 human clinic in Singapore) as a place for treating chronic diseases and symptoms related to microbes and clinical research, and a drug discovery business aiming for new treatments for chronic diseases and symptoms using data and samples obtained from both businesses. KINS aims to free more people from various microbe-related chronic diseases and symptoms in men, women, and animals.
Company Profile
Company Name: KINS Co., Ltd.
Location: 1-17-8-328 Shinkiba, Koto-ku, Tokyo
Representative: Minoru Shimokawa
Business Description: Product business, clinic business, and drug discovery business based on microbiome research
Official Website: https://corporate.yourkins.com/
[Inquiries from media regarding this matter]
KINS Co., Ltd. Public Relations: pr@yourkins.com